In this Issue
Keeping retina patients, staff, and physicians safe
Medical Editors’ Page
By Allen C. Ho, MD; and Robert L. Avery, MD
A patient’s medication history led to retinal atrophy and other findings.
By Navneet Mehrotra, MBBS, DNB, FRF; Manish Nagpal, MBBS, MS, FRCS; and Sham Talati, DO
The peculiar shape led to the preservation of good vision.
By Sebastian M. Waldstein, MD, PhD; Ji Li, MBBS; and Adrian T. Fung, MBBS, MMED, FRANZCO
SPOTLIGHT COVERAGE ON AGE-RELATED MACULAR DEGENERATION
Will this imaging modality lead to better assessment of patients with dry eye disease?
By Luísa S.M. Mendonça, MD; and Caroline R. Baumal, MD
Aided by a large database, researchers explore treatment patterns with anti-VEGF agents.
By Mathew W. MacCumber, MD, PhD
Doctors and patients have found this new mode of therapy beneficial.
By Hakan Kaymak, MD; and Hartmut Schwahn, PhD
A summary of my 2019 Wendell L. Hughes Lecture.
By Carol L. Shields, MD
Answers to questions about managing surgical complications and teaching trainees.
Interview by Nimesh Patel, MD; and Nicolas Yannuzzi, MD; With Jayanth Sridhar, MD
Two fluocinolone acetonide formulations—a newly approved one and a familiar one—offer options for long-term inflammation control.
By Stephen D. Anesi, MD, FACS; and Peter Y. Chang, MD
Developing a custom-made needle for suprachoroidal steroid injections in Syria.
By Ameen Marashi, MD; and Benjamin J. Thomas, MD
CONTINUING COVERAGE OF COVID-19 IN RETINA
When we think of what the future may hold, it behooves us to think from a public health perspective.
By Rahul Reddy, MD, MHS
Special precautions are required to safely and quickly treat patients with potential infection.
By Vamsee Neerukonda, MD; Kevin Rosenberg, MD; and Patrick Oellers, MD
Two studies have implications for improving the safety of patients and providers during the current pandemic.
By Cara E. Capitena Young, MD; and Malik Y. Kahook, MD
COVID-19 has changed the way we think about telemedicine and treatment decisions. Is retina ready for telemedicine? How much have treatment decisions actually changed?
By David A. Eichenbaum, MD
Retina specialists can use this time to gather information about the feasibility of teleophthalmology consultations.
By Edward S. Lu, BA; S.K. Steven Houston III, MD; Ehsan Rahimy, MD; and John B. Miller, MD
Many ophthalmology meetings set to be held this spring have been rescheduled, postponed, or canceled. This list is accurate as of Retina Today’s press date in mid-May.